Total Payments
$2,789
2024 Payments
$32.92
Companies
30
Transactions
171
Medicare Patients
5,167
Medicare Billing
$349,482
Payment Breakdown by Category
Food & Beverage$2,739 (98.2%)
Education$49.60 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,739 | 169 | 98.2% |
| Education | $49.60 | 2 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $464.53 | 17 | $0 (2020) |
| GlaxoSmithKline, LLC. | $430.35 | 38 | $0 (2022) |
| Novo Nordisk Inc | $196.59 | 12 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $193.64 | 14 | $0 (2020) |
| Actelion Pharmaceuticals US, Inc. | $171.92 | 7 | $0 (2020) |
| Gilead Sciences, Inc. | $144.04 | 9 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $132.12 | 7 | $0 (2019) |
| Mylan Specialty L.P. | $106.19 | 7 | $0 (2020) |
| Inspire Medical Systems, Inc. | $105.74 | 1 | $0 (2018) |
| Lilly USA, LLC | $94.05 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32.92 | 1 | Pulmonx Corporation ($32.92) |
| 2022 | $21.43 | 1 | GlaxoSmithKline, LLC. ($21.43) |
| 2020 | $161.83 | 9 | Actelion Pharmaceuticals US, Inc. ($36.43) |
| 2019 | $801.59 | 47 | Boehringer Ingelheim Pharmaceuticals, Inc. ($127.98) |
| 2018 | $991.48 | 55 | Boehringer Ingelheim Pharmaceuticals, Inc. ($164.20) |
| 2017 | $779.29 | 58 | GlaxoSmithKline, LLC. ($157.12) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | Pulmonx Corporation | ZEPHYR DELIVERY CATHETER (Device), PULMONX CHARTIS TABLET CONSOLE, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: PULMONOLOGY | ||||||
| 03/02/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: IMMUNOLOGY | ||||||
| 03/12/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: RESPIRATORY | ||||||
| 03/11/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: RESPIRATORY | ||||||
| 02/04/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Diabetes | ||||||
| 01/28/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $36.43 | General |
| Category: Cardiology | ||||||
| 01/28/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Respiratory | ||||||
| 01/15/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Respiratory | ||||||
| 01/14/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: RESPIRATORY | ||||||
| 01/09/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Respiratory | ||||||
| 01/08/2020 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Respiratory and Allergy | ||||||
| 12/16/2019 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Diabetes | ||||||
| 12/03/2019 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Pulmonology | ||||||
| 11/14/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Diabetes | ||||||
| 11/12/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $86.15 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Respiratory | ||||||
| 10/29/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Diabetes | ||||||
| 10/11/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $0.25 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2019 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Pulmonology | ||||||
| 09/12/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: VACCINES | ||||||
| 09/10/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 474 | 513 | $159,883 | $40,014 |
| 2022 | 8 | 554 | 594 | $146,962 | $44,917 |
| 2021 | 23 | 1,900 | 2,211 | $327,873 | $131,141 |
| 2020 | 30 | 2,239 | 2,601 | $373,869 | $133,410 |
Total Patients
5,167
Total Services
5,919
Medicare Billing
$349,482
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 107 | $37,681 | $9,676 | 25.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 73 | 73 | $27,083 | $6,497 | 24.0% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 68 | 69 | $23,460 | $6,236 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $14,260 | $3,340 | 23.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 36 | 36 | $11,808 | $3,177 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 36 | 43 | $11,567 | $2,991 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 50 | $12,500 | $2,907 | 23.3% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 25 | 25 | $11,150 | $2,709 | 24.3% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 66 | 67 | $8,166 | $2,007 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 12 | $2,208 | $471.51 | 21.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 107 | $27,748 | $9,436 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 113 | $20,069 | $7,452 | 37.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 57 | 60 | $17,646 | $5,772 | 32.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 53 | 54 | $15,136 | $5,072 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 37 | 37 | $13,202 | $3,403 | 25.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 57 | 57 | $13,997 | $2,907 | 20.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $6,120 | $1,915 | 31.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 20 | 20 | $4,524 | $1,708 | 37.7% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 21 | 21 | $7,014 | $1,561 | 22.3% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 12 | 12 | $5,263 | $1,555 | 29.6% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2022 | 53 | 53 | $6,432 | $1,522 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 27 | 29 | $5,414 | $1,374 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 16 | 16 | $4,397 | $1,240 | 28.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 341 | 547 | $118,908 | $50,392 | 42.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 237 | 275 | $40,975 | $19,836 | 48.4% |
About Dr. Thomas Murphy, MD
Dr. Thomas Murphy, MD is a Pulmonary Disease healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144272931.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Murphy, MD has received a total of $2,789 in payments from pharmaceutical and medical device companies, with $32.92 received in 2024. These payments were reported across 171 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,739).
As a Medicare-enrolled provider, Murphy has provided services to 5,167 Medicare beneficiaries, totaling 5,919 services with total Medicare billing of $349,482. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Sleep Medicine
- Location Winchester, VA
- Active Since 05/17/2006
- Last Updated 05/28/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1144272931
Products in Payments
- OFEV (Drug) $226.51
- NUCALA (Biological) $143.00
- ELIQUIS (Drug) $132.12
- ANORO (Drug) $113.50
- Inspire Upper Airway Stimulation System (Device) $105.74
- SYMBICORT (Drug) $101.53
- BREO (Drug) $97.12
- STIOLTO (Drug) $92.18
- TRELEGY ELLIPTA (Drug) $76.73
- ORENITRAM (Drug) $74.44
- Ozempic (Drug) $73.50
- Xolair (Biological) $71.49
- Yupelri (Drug) $61.80
- Letairis (Drug) $61.73
- Tresiba (Drug) $58.90
- UPTRAVI (Drug) $58.41
- OPSUMIT MACITENTAN (Drug) $57.52
- Victoza (Drug) $53.61
- Prolastin-C Liquid (Biological) $52.58
- Zemaira (Biological) $49.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Winchester
T. Bouder, Md, MD
Pulmonary Disease — Payments: $143,021
Pulmonary Disease $143,021
Santa Dalessio, Md, MD
Pulmonary Disease — Payments: $51,548
Pulmonary Disease $51,548
Dr. Christian Lafalce, M.d, M.D
Pulmonary Disease — Payments: $19,760
Pulmonary Disease $19,760
Dr. Oscar Hernandez-Cano, M.d, M.D
Pulmonary Disease — Payments: $4,815
Pulmonary Disease $4,815
Gordon Wolfe, Md, MD
Pulmonary Disease — Payments: $895.05
Pulmonary Disease $895.05
Dr. David Lecronier, D.o, D.O
Pulmonary Disease — Payments: $540.82
Pulmonary Disease $540.82